In the recently published Labiotech-ranking of European Biotech Incubators, COBIS, makes the list as the only Danish and Medicon Valley based incubator. There are, however, two Swedish incubators on the list, which also includes AstraZeneca BioVentureHub in Mölndal and Umeå
Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.
MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.
If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.
The recently published State of the Øresund region analysis covers a broad range of highly relevant issues including infra-structure and traffic, cultural collaboration and health care and life science. As part of the latter, MVA CEO, Petter Hartman is interviewed
“Sweden has strong innovation environments and a tradition of commercialisation. Denmark has large investors in pharmaceuticals as well as capital-rich private foundations. This creates exciting dynamics and makes us more competitive”, says MVA CEO Petter Hartman in a recently published
The Danish-Swedish ReproUnion collaboration continues to make a positive difference to patients, researchers and everybody else interested in the way fertility/infertility affects us as individuals and society as a whole. From a patient perspective the infertility counselling initiative located at
September 25th,the student-driven organisation Synapse – Life Science Connect, that creates events, workshops, and networking opportunities for students and young professionals with an interest in pursuing careers in the life science industry hosted a very succesful career fair indicating a
In Stockholm, Sweden, the The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) recently gathered experts and companies working on multiple sclerosis. Among the presenters were the Danish antibody developer Genmab, which presented results from its drug ofatumumab,
There is good news for early-stage Nordic start-ups in medtech, biotech and pharma. In 2019, BioInnovation Institute will award an extra DKK 35M which will amount to a total of DKK 150M awarded to life science projects since the inauguration
In the recently published index, published by Economist Intelligence Unit, Copenhagen scored 96.8 out of 100 thanks to top scores (100) in Infrastructure and Education, while the city also achieved high scores (over 95) in the other categories: Stability, Healthcare
Macrophage Pharma Limited (‘MPL’), a company focused on the discovery and development of next-generation immunomodulatory small molecules inducing transcriptional reprofiling of macrophages to combat cancer and other diseases, announced today that it has appointed Dr Soren Bregenholt as Chief Executive